Explore News By Topic

11/21/2017

Star-Studded Album Honoring Dan Fogelberg Will Benefit the Prostate Cancer Foundation

LOS ANGELES, November 21, 2017 - The highly-anticipated album, A Tribute to Dan Fogelberg, is now available on CD, digital and streaming platforms. Released worldwide through BMG, sales will benefit the Prostate Cancer Foundation (PCF), a cause near and dear to Dan’s wife, Jean Fogelberg. In 2008, a year after Dan Fogelberg... Read More

10/12/2017

PCF-Funded Researchers at the Cleveland Clinic Reveal Biomarker for Guiding Prostate Cancer Treatment

October 12, 2017, Cleveland:  Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that men who inherit this variant would benefit... Read More

10/05/2017

Prostate Cancer Foundation Announces 2017 PCF Challenge Awards to Accelerate the Development of New Treatments for Advanced Prostate Cancer

WASHINGTON, D.C., October 5, 2017 – The Prostate Cancer Foundation (PCF) today announced awards totaling $7.5 million to fund new 2017 PCF Challenge Awards supporting international, cross-disciplinary teams of investigators conducting pioneering research into critical, unmet medical needs in areas that have the highest potential for impacting and extending lives... Read More

09/18/2017

New Biomarker Predicts Metastatic Prostate Cancers

Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are prone to becoming aggressive and spreading beyond the prostate, making them difficult to treat and life-threatening. Currently, doctors have limited ability to predict which newly diagnosed... Read More

09/14/2017

The Prostate Cancer Foundation, in Collaboration With World’s Leading Researchers, Publish Standard Setting Comprehensive Patient Guide

Guide Offers Recommendations on Newest Life-Extending Treatments for Men with Metastatic Prostate Cancer and their Families LOS ANGELES, CA, September 14, 2017 – The Prostate Cancer Foundation, in honor of Prostate Cancer Awareness Month this September, today released the Prostate Cancer Patient Guide, a new, comprehensive health guide for prostate cancer... Read More

09/05/2017

Dax Shepard, Dr. Drew Pinsky and Rob Riggle Join the Prostate Cancer Foundation with an Urgent Plea to ‘Save the Males’ for Prostate Cancer Awareness Month

LOS ANGELES, CA, September 5, 2017 – – In recognition of Prostate Cancer Awareness Month, Many vs Cancer (MvC) today launched its new campaign, Save the Males, with support from Dax Shepard, Dr. Drew Pinsky and Rob Riggle. This new campaign from the Prostate Cancer Foundation’s MvC initiative aims to... Read More

08/23/2017

Prostate Cancer Foundation Announces Six 2017 Challenge Awards Funded in Partnership with the Movember Foundation

SANTA MONICA, CA, August 23, 2017 – The Prostate Cancer Foundation (PCF) today announced six new Challenge Awards funded in partnership with the Movember Foundation. These multi-year awards support cross-disciplinary teams of investigators conducting pioneering research to advance treatments and cures for prostate cancer. PCF received a donation of $5.4... Read More

08/10/2017

Statistical Shortcut Could Speed Evaluation of Prostate Cancer Drugs

Clinical trials of adjuvant therapies used in treating some men with prostate cancer could be completed more quickly by using a “surrogate” endpoint, scientists report The investigators found that metastasis-free survival – how long patients survived without the cancer spreading – was a strong predictor of their overall survival BOSTON,... Read More

08/04/2017

Researchers make mathematical crystal ball to gaze into future of prostate cancer treatment

Aurora, CO, August 4, 2017 - The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. These patients may have been better off with another treatment or alternative dosing of docetaxel... Read More

08/02/2017

Comprehensive sequencing program shows promise of precision medicine for advanced cancer

ANN ARBOR, Michigan, August 2, 2017 — The average metastatic cancer has more genetic mutations than are seen in early stage tumors, a new study finds. What that means: To make precision medicine a reality in cancer care, you need a real-time, comprehensive approach that looks at the metastatic tumors... Read More